22NW, LP - PSYCHEMEDICS CORP ownership

PSYCHEMEDICS CORP's ticker is PMD and the CUSIP is 744375205. A total of 36 filers reported holding PSYCHEMEDICS CORP in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
22NW, LP ownership history of PSYCHEMEDICS CORP
ValueSharesWeighting
Q3 2023$1,089,439
+183.7%
274,418
+263.3%
0.78%
+466.4%
Q4 2020$384,000
+15.0%
75,534
-0.1%
0.14%
-18.9%
Q3 2020$334,000
-26.4%
75,634
-7.5%
0.17%
-31.3%
Q2 2020$454,000
+173.5%
81,736
+198.3%
0.25%
+90.7%
Q1 2020$166,00027,4000.13%
Other shareholders
PSYCHEMEDICS CORP shareholders Q2 2020
NameSharesValueWeighting ↓
Tieton Capital Management, LLC 256,359$4,725,0004.06%
Moors & Cabot, Inc. 337,060$6,218,0000.90%
CARL DOMINO INC 11,236$207,0000.25%
Gs Investments, Inc. 15,500$285,665,0000.23%
Ativo Capital Management LLC 46,327$854,0000.23%
North Star Investment Management Corp. 78,271$1,443,0000.18%
RBF Capital, LLC 78,495$1,447,0000.18%
Uniplan Investment Counsel, Inc. 191,822$3,535,0000.15%
QUANTUM CAPITAL MANAGEMENT 30,669$565,0000.13%
CRAWFORD INVESTMENT COUNSEL INC 205,493$3,787,0000.12%
View complete list of PSYCHEMEDICS CORP shareholders